Select Page

Category: U.S. Food and Drug Administration

Lori: FDA decision on medical abortion puts women’s lives, health at risk

By no longer requiring the abortion drug mifepristone to be picked up in person, the U.S. Food and Drug Administration is “merely succumbing to the abortion industry’s pressure to loosen safety standards,” instead of protecting the lives and health of mothers and children as it should do, said the U.S. bishops’ pro-life chairman.

Read More

Bishops address concern over Johnson & Johnson vaccine’s abortion link

Use of the Johnson & Johnson COVID-19 vaccine, approved Feb. 27 by the U.S. Food and Drug Administration, raises moral concerns because it was “was developed, tested and is produced with abortion-derived cell lines,” the chairmen of two U.S. bishops’ committees said March 2.

Read More

Head of FDA urged to ensure any COVID vaccine be free of abortion connection

The chairmen of four U.S. bishops’ committees, joined by the leaders of several health care, bioethics and pro-life organizations, “urgently and respectfully” implored the commissioner of the U.S. Food and Drug Administration to ensure any vaccines developed for the coronavirus “are free from any connection to abortion.”

Read More
Loading

Recent Comments

    Archives

    Categories